Related Experiment Videos
[Suppression of transforming growth factor beta 1 on malignant phenotype in HL-60 cells]
1Institute for Environmental Surveillance, Chinese Academy of Preventive Medicine, Beijing.
Objective:
To study the effect of transforming growth factor beta 1 on tumor cells.
Method:
HL-60 cells were transfected with transforming growth factor beta 1 expression vector by electroporation. Stable cell clones resistant to G 418 were obtained after 2-3 week growth with the drug-containing medium. A series of malignant phenotype were compared between transfected and untransfected HL 60 cells.
Results:
The growth speed of HL-60 cells which overexpressed transforming growth factor beta 1 mRNA decreased significantly. Clonigenecity in soft agarase and tumor formation in athymic mice were lower than those untransfected HL-60 cells.
Conclusion:
Suppression effect of transforming growth factor beta 1 on malignant phenotype in HL-60 cells were demonstrated.
Insights
Transforming growth factor beta 1 (TGF-β1) suppresses tumor cell growth and malignancy. Overexpression of TGF-β1 in HL-60 cells reduced their growth speed, soft agar colony formation, and tumor formation in mice.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Context:
- Transforming growth factor beta 1 (TGF-β1) is a cytokine with complex roles in cell growth and differentiation.
- The role of TGF-β1 in regulating the malignant phenotype of leukemia cells requires further elucidation.
Purpose:
- To investigate the functional impact of TGF-β1 overexpression on the malignant characteristics of HL-60 leukemia cells.
Summary:
- HL-60 cells were engineered to overexpress TGF-β1 via transfection with an expression vector.
- Stable clones were selected, and their malignant phenotypes were compared to control cells.
- Results indicated that TGF-β1 overexpression significantly reduced HL-60 cell proliferation, clonogenicity in soft agar, and in vivo tumor formation in athymic mice.
Impact:
- Demonstrates a tumor-suppressive role for TGF-β1 in HL-60 leukemia.
- Highlights the potential of TGF-β1 as a therapeutic target for certain cancers.
- Provides insights into the molecular mechanisms underlying leukemia progression and suppression.